Abstract
Pooled CRISPR screens are emerging as a powerful tool to dissect regulatory networks, by assessing how a protein responds to genetic perturbations in a highly multiplexed manner. A large number of genes are perturbed in a cell population through genomic integration of one single-guide RNA (sgRNA) per cell. A subset of cells with the phenotype of interest can then be enriched through fluorescence-activated cell sorting (FACS). SgRNAs with altered abundance after phenotypic enrichment allow identification of genes that either promote or attenuate the investigated phenotype. Here we provide detailed guidelines on how to design and execute a pooled CRISPR screen to investigate molecular phenotypes. We describe how to generate a custom sgRNA library and how to perform a FACS-based screen using readouts such as intracellular antibody staining or Flow-FISH to assess phosphorylation levels or RNA abundance. Through the variety of available perturbation systems and readout options many different molecular and cellular phenotypes can now be tackled with pooled CRISPR screens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jackson AL, Bartz SR, Schelter J et al (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635–637
Jackson AL, Linsley PS (2010) Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9:57–67
Shalem O, Sanjana NE, Hartenian E et al (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84–87
Wang T, Wei JJ, Sabatini DM et al (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science 343:80–84
Gilbert LA, Horlbeck MA, Adamson B et al (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159:647–661
Konermann S, Brigham MD, Trevino AE et al (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517:583–588
Klann TS, Black JB, Chellappan M et al (2017) CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome. Nat Biotechnol 35:561–568
Liu SJ, Horlbeck MA, Cho SW et al (2017) CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science 355:aah7111
Diao Y, Fang R, Li B et al (2017) A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells. Nat Methods 14:629–635
Zhu S, Li W, Liu J et al (2016) Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol 34:1279–1286
Korkmaz G, Lopes R, Ugalde AP et al (2016) Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9. Nat Biotechnol 34:192–198
Datlinger P, Rendeiro AF, Schmidl C et al (2017) Pooled CRISPR screening with single-cell transcriptome readout. Nat Methods 14:297–301
Jaitin DA, Weiner A, Yofe I et al (2016) Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-Seq. Cell 167:1883–1896.e15
Dixit A, Parnas O, Li B et al (2016) Perturb-Seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens. Cell 167:1853–1866.e17
Yeo NC, Chavez A, Lance-Byrne A et al (2018) An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat Methods 15:611–616
Wessels H-H, Méndez-Mancilla A, Guo X et al (2020) Massively parallel Cas13 screens reveal principles for guide RNA design. Nat Biotechnol 38:722–727
Wei J, Lotfy P, Faizi K, et al (2021) Deep learning of Cas13 guide activity from high-throughput gene essentiality screening. BioRxiv
Chavez A, Scheiman J, Vora S et al (2015) Highly efficient Cas9-mediated transcriptional programming. Nat Methods 12:326–328
Miles LA, Garippa RJ, Poirier JT (2016) Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens. FEBS J 283:3170–3180
Gerhards NM, Rottenberg S (2018) New tools for old drugs: functional genetic screens to optimize current chemotherapy. Drug Resist Updat 36:30–46
Behan FM, Iorio F, Picco G et al (2019) Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature 568:511–516
Parnas O, Jovanovic M, Eisenhaure TM et al (2015) A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks. Cell 162:675–686
Genolet O, Monaco AA, Dunkel I et al (2021) Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach. Genome Biol 22:110
Fulco CP, Nasser J, Jones TR et al (2019) Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat Genet 51:1664–1669
Gjaltema RA, Schwammle T, Kautz P et al (2022) Distal and proximal cis-regulatory elements sense X-chromosomal dosage and developmental state at the Xist locus. Mol Cell 82: 190–208
Reilly SK, Gosai SJ, Gutierrez A et al (2021) Direct characterization of cis-regulatory elements and functional dissection of complex genetic associations using HCR-FlowFISH. Nat Genet 53:1166–1176
Nagy T, Kampmann M (2017) CRISPulator: a discrete simulation tool for pooled genetic screens. BMC Bioinformatics 18:347
Imkeller K, Ambrosi G, Boutros M et al (2020) gscreend: modelling asymmetric count ratios in CRISPR screens to decrease experiment size and improve phenotype detection. Genome Biol 21:53
Doench JG, Fusi N, Sullender M et al (2016) Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 34:184–191
Morgens DW, Wainberg M, Boyle EA et al (2017) Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens. Nat Commun 8:15178
Horlbeck MA, Gilbert LA, Villalta JE et al (2016) Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife 5:e19760
Sanson KR, Hanna RE, Hegde M et al (2018) Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun 9:5416
Sanjana NE, Shalem O, Zhang F (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11:783–784
Chen B, Gilbert LA, Cimini BA et al (2013) Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155:1479–1491
Henkel L, Rauscher B, Schmitt B et al (2020) Pooled CRISPR screening at high sensitivity with an empirically designed sgRNA library. BMC Biol 18:174
Zhang J, Chen L, Zhang J et al (2019) Drug inducible crispr/cas systems. Comput Struct Biotechnol J 17:1171–1177
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Genolet, O., Ravid Lustig, L., Schulz, E.G. (2022). Dissecting Molecular Phenotypes Through FACS-Based Pooled CRISPR Screens. In: Turksen, K. (eds) Embryonic Stem Cell Protocols . Methods in Molecular Biology, vol 2520. Humana, New York, NY. https://doi.org/10.1007/7651_2021_457
Download citation
DOI: https://doi.org/10.1007/7651_2021_457
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2436-4
Online ISBN: 978-1-0716-2437-1
eBook Packages: Springer Protocols